Chargement en cours...
Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line
AIM: To investigate the effect and mechanism of action of erlotinib, an epidermal growth factor receptor (EGFR) small molecule tyrosine kinase inhibitor (TKI), in the human pancreatic cancer cell line BxPC-3 both in vitro and in vivo. METHODS: In vitro, human pancreatic cancer cell line BxPC-3 was e...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The WJG Press and Baishideng
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2744159/ https://ncbi.nlm.nih.gov/pubmed/18803351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.5403 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|